Hepatitis C - Annual Epidemiological Report for 2017
In 2017, 31 273 cases of hepatitis C were reported in 29 EU/EEA Member States. Excluding countries that only reported acute cases, 31 178 cases corresponds to a crude rate of 7.3 cases per 100 000 population.
Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA
The scope of this project was to provide an overview of different effective testing strategies for hepatitis B and C and their outcomes in the EU/EEA, covering all relevant population groups and settings.
Public health guidance in brief on HIV, hepatitis B and C testing in the EU/EEA
The ECDC guidance on integrated testing of hepatitis B (HBV), hepatitis C (HCV) and HIV supports countries in the global effort to combat viral hepatitis and eliminate HIV as public health threats by 2030. At present, reaching and testing those at risk of infection with HIV, HBV or HCV is still a public health challenge across Europe. This Guidance in brief is based on the comprehensive guidance document which provides the evidence base for this guidance
Public health guidance on HIV, hepatitis B and C testing in the EU/EEA
This guidance aims to provide EU/EEA countries with an evidence-based framework to help develop, implement, monitor and evaluate their own national HBV, HCV and HIV testing guidelines and programmes.
Accessibility and acceptability of infectious disease interventions among migrants in the eu/eea: A cerqual systematic review
Driedger, M., Mayhew, A., Welch, V., Agbata, E., Gruner, D., Greenaway, C., Noori, T., Sandu, M., Sangou, T., Mathew, C., Kaur, H., Pareek, M., Pottie, K.
The effectiveness and cost-effectiveness of hepatitis c screening for migrants in the EU/EEA: A systematic review
Greenaway, C., Makarenko, I., Chakra, C.N.A., Alabdulkarim, B., Christensen, R., Palayew, A., Tran, A., Staub, L., Pareek, M., Meerpohl, J.J., Noori, T., Veldhuijzen, I., Pottie, K., Castelli, F., Morton, R.L.
Hepatitis B and C epidemiology in selected population groups in the EU/EEA
The findings presented in this report will be part of the process of developing a European guidance for HBV and HCV testing and may provide support EU/EEA countries in the development of national guidelines and in the design and scale-up of testing interventions.
A systematic review on models of care effectiveness and barriers to Hepatitis C treatment in prison settings in the EU/EEA
Vroling, H., Oordt-Speets, A.M., Madeddu, G., Babudieri, S., Monarca, R., O'Moore, E., Vonk Noordegraaf-Schouten, M., Wolff, H., Montanari, M., Hedrich, D., Tavoschi, L.
Public health guidance on prevention and control of blood-borne viruses in prison settings
This document provides EU/EEA Member States with evidence-based scientific advice on available options, when planning and implementing prevention and control interventions for blood-borne viruses in prison settings.
Guidance in brief: Prevention and control of blood-borne viruses in prison settings
This guidance is intended for policymakers responsible for the planning and delivery of healthcare services in the national or sub-national custodial system and all professionals responsible for the health and well-being of people in prison, including community-based service providers and those facilitating continuity of care in the community.